Labrosse J

No ORCID on file · 4 papers in corpus
other 2026
Preferred clinical protocols for the management of LH/FSH deficiency: a practitioner opinion survey
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2026.103324

BACKGROUND: Today's clinical guidelines do not fully address clinical situations associated with combined functional luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiencies linked to advanced maternal age, gonadotropin-…

observational 2023
Higher risk of pre-eclampsia and other vascular disorders with artificial cycle for frozen-thawed embryo transfer compared to ovulatory cycle or to fresh embryo transfer following in vitro fertilization
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1182148

BACKGROUND: Risks of maternal morbidity are known to be reduced in pregnancies resulting from frozen embryo transfer (FET) compared to fresh-embryo transfer (fresh-ET), except for the risk of pre-eclampsia, reported to be higher in FET preg…

observational 2022
Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles)
Human reproduction open ·doi:10.1093/hropen/hoac007

STUDY QUESTION: Does the endometrial preparation protocol (artificial cycle (AC) vs natural cycle (NC) vs stimulated cycle (SC)) impact the risk of early pregnancy loss and live birth rate after frozen/thawed embryo transfer (FET)? SUMMARY…

observational 2022
Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00958-7

BACKGROUND: In absence of contraindication, breast cancer patients of reproductive age can undergo fertility preservation with controlled ovarian stimulation for oocyte/embryo cryopreservation before the administration of potentially gonado…